Policy team

We aim to influence policy developments so that researchers can be as effective as possible and health can be improved.

We work with a wide range of partners – including governments, research funders, learned societies, charities and commercial organisations – in the UK, Europe and globally. 

Policy Directorate

Ed Whiting

Director of Policy and Chief of Staff

Natalie Paloma-Solis

Executive Assistant to Ed Whiting

UK and EU Policy

Beth Thompson

Head of UK and EU Policy

Michelle Marshall

PA and Team Coordinator

Stuart Pritchard

EU and Public Affairs Manager

Contact about:

Brexit, public affairs, relationship management, EU health and research policy.

Louise Wren

Policy Manager

Contact about:

Brexit, UK research and innovation.

Sam Alvis

Policy Officer

Contact about:

gene editingresearch involving animals, EU funding and regulation.

Natalie Banner

Policy Adviser

Ben Bleasdale

Policy Adviser

Contact about:

UK research investment, funding structures, Research Excellence Framework, What’s it Worth studies.

Katherine Powell

Policy Officer

Contact about:

EU medical devices regulations, immigration, innovation policy, All-Party Parliamentary Group on Medical Research, parliamentary communications, diversity.

Sarah Rappaport

Policy Adviser

Contact about:

gene editing, mitochondrial donation, regulation of clinical trials, research in the NHS, research involving embryos.

Global Policy

Nancy Lee

Global Policy Lead

Katherine Littler

Global Policy Lead

Stacha Hicks

Interim Team Coordinator

Heather Browett

Policy Officer

Contact about:

access to medicines, emerging technologies.

Rachael Crockett

Policy Adviser

Contact about:

global review of health research financing, vaccines.

Adrienne Hunt

Research Ethics and Governance Manager

Contact about:

research ethics and governance, UK Biobank Ethics and Governance Council, Global Forum on Bioethics in Research.

James Hynard

Policy Officer

Contact about:

access to medicines, drug-resistant infections.

Alice Jamieson

Policy Officer

Diogo Martins

Policy Officer

Contact about:

global review of health research financing.

Anna Ruddock

Policy Adviser

Contact about:

research uptake.

Our work

Open research

We want the research we fund – like publications, data, software and materials – to be open and accessible, so it can have the greatest possible impact.

Brexit and the EU

We're working with the UK government and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.

Patient data in research

Patient data is hugely valuable for research. But the value of that data can only be unlocked if concerns about patient privacy are taken seriously.

Research practice

Good research practice is one of the foundations of high-quality research.

Government investment in research

Government investment plays an important part in supporting scientific excellence in the UK.

Data sharing in public health emergencies

Research is an essential part of being ready for and responding to public health emergencies.

Accelerated Access Review

The recommendations set out in the review mark one of the first steps towards making sure that promising drugs, devices, diagnostics and digital products are adopted quickly across the NHS.

Gene editing in research

Gene editing allows scientists to change gene sequences by adding, replacing or removing sections of DNA.

Data Protection Regulation

The new European Data Protection Regulation was agreed in April 2016 and will take effect from May 2018.

EU copyright law reform

The European Commission has published a proposal to update EU copyright law so that it applies equally across Europe and is fit for purpose in the 21st century.

Research involving animals

Almost every major breakthrough in human and veterinary medicine has depended on the use of animals in the research, development or testing of new therapies. 

Mitochondrial donation

Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.

EU medical devices regulations

The European Union is revising regulations governing the manufacture and sale of medical devices.

Expert Advisory Group on Data Access

The Expert Advisory Group on Data Access promoted good working practices, consistent governance and transparent decision making for managing and using data from cohort studies.


Evidence synthesis on the EU-UK relationship on research and innovation [PDF 383KB]

  • January 2018

A synthesis of the existing evidence on the EU-UK relationship on research and innovation, produced by the Royal Society.

What's it worth? [PDF 149KB]

  • January 2018

A briefing on the economic benefits of musculoskeletal disease research in the UK.

Consultation on the future EU-UK relationship on research and innovation [PDF 337KB]

  • January 2018

Together with the Royal Society, we asked individuals and organisations from across the UK and EU for their recommendations about how future research and innovation partnerships should work after Brexit.

More reports

Briefings and responses

EEA-workers in the UK labour market [PDF 294KB]

  • November 2017

Migratory Advisory Committee

Science budget and Industrial Strategy inquiry [PDF 247KB]

  • November 2017

House of Commons Science and Technology Committee

More briefings and responses